Back to Search Start Over

Spatial metabolomics reveals glycogen as an actionable target for pulmonary fibrosis.

Authors :
Conroy LR
Clarke HA
Allison DB
Valenca SS
Sun Q
Hawkinson TR
Young LEA
Ferreira JE
Hammonds AV
Dunne JB
McDonald RJ
Absher KJ
Dong BE
Bruntz RC
Markussen KH
Juras JA
Alilain WJ
Liu J
Gentry MS
Angel PM
Waters CM
Sun RC
Source :
Nature communications [Nat Commun] 2023 May 13; Vol. 14 (1), pp. 2759. Date of Electronic Publication: 2023 May 13.
Publication Year :
2023

Abstract

Matrix assisted laser desorption/ionization imaging has greatly improved our understanding of spatial biology, however a robust bioinformatic pipeline for data analysis is lacking. Here, we demonstrate the application of high-dimensionality reduction/spatial clustering and histopathological annotation of matrix assisted laser desorption/ionization imaging datasets to assess tissue metabolic heterogeneity in human lung diseases. Using metabolic features identified from this pipeline, we hypothesize that metabolic channeling between glycogen and N-linked glycans is a critical metabolic process favoring pulmonary fibrosis progression. To test our hypothesis, we induced pulmonary fibrosis in two different mouse models with lysosomal glycogen utilization deficiency. Both mouse models displayed blunted N-linked glycan levels and nearly 90% reduction in endpoint fibrosis when compared to WT animals. Collectively, we provide conclusive evidence that lysosomal utilization of glycogen is required for pulmonary fibrosis progression. In summary, our study provides a roadmap to leverage spatial metabolomics to understand foundational biology in pulmonary diseases.<br /> (© 2023. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
14
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
37179348
Full Text :
https://doi.org/10.1038/s41467-023-38437-1